
Loading, please wait...

Loading, please wait...

Hepatocellular carcinoma (HCC) remains a significant clinical challenge in India due to late-stage diagnosis and metabolic flexibility. Recent findings demonstrate that TRIB3 HCC metabolic adaptation serves as a critical survival mechanism when glutamine levels are low. Researchers discovered that TRIB3, a pseudokinase, acts as a nuclear safeguard for DNA repair fidelity during nutrient stress.
Furthermore, the study explains that glutamine deprivation triggers c-Jun-dependent upregulation of TRIB3. This protein subsequently binds to G-quadruplex DNA (G4-DNA) structures across the genome. Specifically, TRIB3 recruits the helicase DDX5 to resolve these complex structures. Consequently, this cooperative functional complex maintains the transcription of essential homologous recombination genes like BRCA1 and RAD51AP1.
Without the TRIB3-DDX5 complex, HCC cells suffer from exaggerated G4-DNA accumulation. This leads to replication catastrophe and heightened DNA damage. Therefore, researchers suggest that TRIB3 levels correlate directly with poor clinical outcomes. Additionally, in vivo experiments showed that silencing TRIB3 suppresses xenograft growth, particularly when combined with glutamine-deficient diets. Thus, targeting the TRIB3-DDX5-G4 axis offers a promising therapeutic strategy for TRIB3-high malignancies.
TRIB3 facilitates metabolic adaptation by recruiting DDX5 to resolve G-quadruplex DNA structures. This action ensures that DNA repair genes remain active, preventing genomic instability and replication catastrophe.
Depleting TRIB3 causes G-quadruplexes to accumulate, which blocks the transcription of repair genes like BRCA1. This leads to increased DNA damage and eventually triggers apoptosis in the cancer cells.
While targeting glutamine alone often fails due to resistance, combining it with TRIB3 inhibition may overcome this adaptive survival mechanism, making tumors more vulnerable to therapy.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or professional services. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


New research identifies the TRIB3-DDX5 axis as a vital mechanism for hepatocellular carcinoma survival by resolving G-quadruplexes during glutamine deprivat...
7 months ago

As monsoon seasons elevate arboviral disease threats, Tamil Nadu has initiated an ICMR-monitored evaluation of the tetravalent dengue vaccine in Tenkasi district. Clinicians emphasize clinical monitoring, public prevention, and high-quality early pediatric care to reduce disease morbidity across endemic regions.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today